Mirae Asset Mutual Fund sold 53,335 shares of Capillary Technologies India Ltd on September 18, 2026, via the open market. The transaction reduced the fund’s holding in the Bengaluru-based digital engagement platform provider to 45 shares.

The sale was disclosed under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Mirae Asset Investment Managers (India) Private Limited filed the disclosure with the Bombay Stock Exchange on September 21, 2026.

Transaction Details

Prior to the sale, Mirae Asset held 53,380 shares, representing 0.07% of the total share capital and 0.06% of the diluted share capital. The open market transaction involved a reduction of 53,335 shares.

Following the transaction, the fund’s holding stands at 45 shares. This equates to 0.00% of the total equity share capital and 0.00% of the total diluted share capital. No warrants, convertible securities, or encumbered shares were involved in the transaction.

What the Numbers Show

The total equity share capital of Capillary Technologies India Ltd remained unchanged at 79,471,983 shares before and after the sale. The total diluted share capital stands at 82,374,238 shares. The reduction in percentage holding is solely due to the decrease in the number of shares held by Mirae Asset, with no change in the company’s outstanding capital structure.

Capillary Technologies India Limited will host an analyst and institutional investor meeting on Monday, September 21, 2026. The event is part of the Anand Rathi Annual Flagship Conference G-200 Summit 2026, held physically in Mumbai.

The company issued this intimation pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This disclosure ensures transparency regarding scheduled interactions with market participants.

Event Details

The meeting will take place in a physical format at the conference venue in Mumbai. Capillary Technologies stated that the schedule may undergo changes due to exigencies on the part of participants or the company.

Regulatory Compliance

The company emphasized that no Unpublished Price Sensitive Information (UPSI) is intended to be discussed during the interaction. This aligns with standard regulatory requirements for public disclosures and investor meetings.

The intimation has been placed on the company’s website under corporate announcements. Gireddy Bhargavi Reddy, Company Secretary and Compliance Officer, signed the disclosure from Bengaluru.